Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.
Clinical trial NCT03843749 · UNKNOWN
Trial details
- NCT number
- NCT03843749
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2019-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.